Is a single dose of ChAdOx1 nCoV‐19 vaccine (AZD1222) enough for people with prior SARS‐CoV‐2 infection or baseline seropositive status?

MLA

Vikas Deswal, et al. “Is a Single Dose of ChAdOx1 NCoV‐19 Vaccine (AZD1222) Enough for People with Prior SARS‐CoV‐2 Infection or Baseline Seropositive Status?” International Journal of Infectious Diseases, vol. 123, Oct. 2022, pp. 143–44. EBSCOhost, https://doi.org/10.1016/j.ijid.2022.06.051.

APA

Vikas Deswal, Rashmi Phogat, Pooja Sharma, Sushila Kataria, & Arvinder Soin. (2022). Is a single dose of ChAdOx1 nCoV‐19 vaccine (AZD1222) enough for people with prior SARS‐CoV‐2 infection or baseline seropositive status? International Journal of Infectious Diseases, 123, 143–144. https://doi.org/10.1016/j.ijid.2022.06.051

Chicago

Vikas Deswal, Rashmi Phogat, Pooja Sharma, Sushila Kataria, and Arvinder Soin. 2022. “Is a Single Dose of ChAdOx1 NCoV‐19 Vaccine (AZD1222) Enough for People with Prior SARS‐CoV‐2 Infection or Baseline Seropositive Status?” International Journal of Infectious Diseases 123 (October): 143–44. doi:10.1016/j.ijid.2022.06.051.